Form 4 Filing: Blount Sally E. Acquires (Grant) shares of $ABT

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

ABBOTT LABORATORIES

Ticker: $ABT

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2023-04-28

Shares: 1,816

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Blount Sally E., holds the title of Director at ABBOTT LABORATORIES.

On 2023-04-28, the insider transacted 1,816 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Blount Sally E. (Director) was granted $0 of $ABT

Post-Transaction Position: 33,157 shares

SEC Accession No: 0001415889-23-007128 (CIK: 1537286)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$ABT Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$ABT News Coverage